Vigabatrin; Its effect on the electrophysiology of vision

Documenta Ophthalmologica

Volumn 104, Issue 2, 2002, Pages 213-229

  Harding, G F A ^a   Robertson, K ^a   Spencer, E L ^a   Holliday, I ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

EOG; ERG; H stimulus; VEP; Vigabatrin; Visual fields

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; CARBAMAZEPINE; PLACEBO; VIGABATRIN;

A WAVE; AMPLITUDE MODULATION; B WAVE; CLINICAL TRIAL; DATA BASE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; ELECTROOCULOGRAPHY; EPILEPSY; HUMAN; LATENT PERIOD; NONHUMAN; OSCILLATORY POTENTIAL; PEDIATRICS; PERIMETRY; PHOTOPIC VISION; RETINA; REVIEW; SENSITIVITY AND SPECIFICITY; SENSORY SYSTEM ELECTROPHYSIOLOGY; VISION; VISUAL FIELD DEFECT; VISUAL STIMULATION; VISUAL SYSTEM PARAMETERS;

ANTICONVULSANTS; ELECTROOCULOGRAPHY; ELECTRORETINOGRAPHY; HUMANS; VIGABATRIN; VISION; VISION DISORDERS;

EID: 0036214531     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014643528474     Document Type: Review

References (29)

1. Severe persistent visual field constriction associated with vigabatrin
2. Vigabatrin therapy for resistant partial epilepsies
3. Severe persistent visual field constriction associated with vigabatrin. Four possible mechanisms exists
4. Vigabatrin-associated retinal cone system dysfunction. Electroretinogram and ophthalmologic findings
5. Outer retinal dysfunction in patients treated with vigabatrin
6. Symptomatic and asymptomatic visual loss in patients taking vigabatrin
7. Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field constriction
8. Visual field defects associated with vigabatrin therapy
9. Characteristics of a unique visual field defect attributed to vigabatrin
10. Visual dysfunction in patients receiving vigabatrin. Clinical and electrophysiological findings
11. Therapeutic trial of vigabatrin in refractory infantile spasms
12. A multicentre study of vigabatrin for drug resistant epilepsy
13. Evoked potential monitoring of vigabatrin patients
14. Effects of vigabatrin on evoked potentials in epileptic patients
15. Effects of long-term vigabatrin on somatosensory-evoked potentials in epileptic patients
16. Electroretinogram, pattern electroretinogram and visual evoked potential assessment in patients receiving vigabatrin
17. No effect of long-term vigabatrin treatment on CNS conduction in epileptic patients: Results of a multicenter study of somatosensory and visual evoked potentials
18. Neuropathologic findings in patients receiving long-term vigabatrin therapy for chronic intractable epilepsy
19. Effects of anticonvulsant drugs on retinal function. Psychophysical and electrophysicological findings in patients with epilepsy
20. Electroretinographic changes are not associated with loss of visual function in paediatric patients following treatment with vigabatrin
21. Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin
22. Separating the retinal electrophysiologic effects of vigabatrin - Treatment versus field loss
23. EOGs, ERGs, VEPs and multifocal ERGs in epileptic patients showing visual field constriction
24. Visual electrophysiological effect of a GABA transaminase blocker
25. Guidelines for basic pattern electroretinography
26. Electrophysiologic evaluation of visual disturbances associated with vigabatrin
27. Guideline may help in prescribing vigabatrin
28. Field-specific visual evoked potentials for assessment of peripheral field defect in a paediatric population